£1.3M
The Liverpool-based stem cell specialist raised the funds from founders, angels, and Spark Impact to scale manufacturing and run clinical trials.
"I am delighted to have secured our initial investment which will leverage our TSB grant. The investment will allow us to formally demonstrate our world-leading technology platform in a scientifically and clinically rigorous way, moving it further towards commercial reality. Sincere thanks to all of our investors for their support."
